Literature DB >> 2464671

Hemopoietins in oncology: factoring out myelosuppression.

J D Griffin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2464671     DOI： 10.1200/JCO.1989.7.2.151

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment.

Authors:  N Thatcher
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  Increased expression of growth factor genes for macrophages and fibroblasts in bronchoalveolar lavage cells of a patient with pulmonary histiocytosis X.

Authors:  J Barth; H Kreipe; H J Radzun; K Heidorn; W Petermann; B Bewig; M R Parwaresch
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

3.  Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens.

Authors:  J Mukai; E Shimizu; T Ogura
Journal:  Jpn J Cancer Res       Date:  1992-07

4.  Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells.

Authors:  G Cimoli; P Russo; G Billi; G L Mariani; E Rovini; M Venturini
Journal:  Jpn J Cancer Res       Date:  1991-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.